BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 25539279)

  • 1. Brain FDG PET and the diagnosis of dementia.
    Shivamurthy VK; Tahari AK; Marcus C; Subramaniam RM
    AJR Am J Roentgenol; 2015 Jan; 204(1):W76-85. PubMed ID: 25539279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of (18)FDG PET and (11)C-PIB PET brain imaging on the diagnosis of Alzheimer's disease and other dementias in a regional memory clinic in Hong Kong.
    Shea YF; Ha J; Lee SC; Chu LW
    Hong Kong Med J; 2016 Aug; 22(4):327-33. PubMed ID: 27313272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients.
    Jeong Y; Cho SS; Park JM; Kang SJ; Lee JS; Kang E; Na DL; Kim SE
    J Nucl Med; 2005 Feb; 46(2):233-9. PubMed ID: 15695781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Cochrane review on brain [¹⁸F]FDG PET in dementia: limitations and future perspectives.
    Morbelli S; Garibotto V; Van De Giessen E; Arbizu J; Chételat G; Drezgza A; Hesse S; Lammertsma AA; Law I; Pappata' S; Payoux P; Pagani M;
    Eur J Nucl Med Mol Imaging; 2015 Sep; 42(10):1487-91. PubMed ID: 26067090
    [No Abstract]   [Full Text] [Related]  

  • 5. Decline of cerebral glucose metabolism in frontotemporal dementia: a longitudinal 18F-FDG-PET-study.
    Diehl-Schmid J; Grimmer T; Drzezga A; Bornschein S; Riemenschneider M; Förstl H; Schwaiger M; Kurz A
    Neurobiol Aging; 2007 Jan; 28(1):42-50. PubMed ID: 16448722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomography imaging in dementia.
    Herholz K; Carter SF; Jones M
    Br J Radiol; 2007 Dec; 80 Spec No 2():S160-7. PubMed ID: 18445746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidance for reading FDG PET scans in dementia patients.
    Herholz K
    Q J Nucl Med Mol Imaging; 2014 Dec; 58(4):332-43. PubMed ID: 25391316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-FDG PET Improves Diagnosis in Patients with Focal-Onset Dementias.
    Taswell C; Villemagne VL; Yates P; Shimada H; Leyton CE; Ballard KJ; Piguet O; Burrell JR; Hodges JR; Rowe CC
    J Nucl Med; 2015 Oct; 56(10):1547-53. PubMed ID: 26251415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of molecular imaging on the diagnostic process in a memory clinic.
    Ossenkoppele R; Prins ND; Pijnenburg YA; Lemstra AW; van der Flier WM; Adriaanse SF; Windhorst AD; Handels RL; Wolfs CA; Aalten P; Verhey FR; Verbeek MM; van Buchem MA; Hoekstra OS; Lammertsma AA; Scheltens P; van Berckel BN
    Alzheimers Dement; 2013 Jul; 9(4):414-21. PubMed ID: 23164552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of global and cerebellar normalization on detection and differentiation of dementia in FDG-PET studies.
    Dukart J; Mueller K; Horstmann A; Vogt B; Frisch S; Barthel H; Becker G; Möller HE; Villringer A; Sabri O; Schroeter ML
    Neuroimage; 2010 Jan; 49(2):1490-5. PubMed ID: 19770055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential diagnosis of neurodegenerative dementias using metabolic phenotypes on F-18 FDG PET/CT.
    Tripathi M; Tripathi M; Damle N; Kushwaha S; Jaimini A; D'Souza MM; Sharma R; Saw S; Mondal A
    Neuroradiol J; 2014 Feb; 27(1):13-21. PubMed ID: 24571830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain fluorodeoxyglucose (FDG) PET in dementia.
    Kato T; Inui Y; Nakamura A; Ito K
    Ageing Res Rev; 2016 Sep; 30():73-84. PubMed ID: 26876244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Single-Subject Brain Metabolic Patterns in the Early Differential Diagnosis of Primary Progressive Aphasias and in Prediction of Progression to Dementia.
    Cerami C; Dodich A; Greco L; Iannaccone S; Magnani G; Marcone A; Pelagallo E; Santangelo R; Cappa SF; Perani D
    J Alzheimers Dis; 2017; 55(1):183-197. PubMed ID: 27662315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-spline-based stereotactical normalization of brain FDG PET scans in suspected neurodegenerative disease: impact on voxel-based statistical single-subject analysis.
    Wenzel F; Young S; Wilke F; Apostolova I; Arlt S; Jahn H; Thiele F; Buchert R
    Neuroimage; 2010 Apr; 50(3):994-1003. PubMed ID: 20053378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain PET in suspected dementia: patterns of altered FDG metabolism.
    Brown RK; Bohnen NI; Wong KK; Minoshima S; Frey KA
    Radiographics; 2014; 34(3):684-701. PubMed ID: 24819789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease.
    Foster NL; Heidebrink JL; Clark CM; Jagust WJ; Arnold SE; Barbas NR; DeCarli CS; Turner RS; Koeppe RA; Higdon R; Minoshima S
    Brain; 2007 Oct; 130(Pt 10):2616-35. PubMed ID: 17704526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regions of interest-based discriminant analysis of DaTSCAN SPECT and FDG-PET for the classification of dementia.
    Garibotto V; Montandon ML; Viaud CT; Allaoua M; Assal F; Burkhard PR; Ratib O; Zaidi H
    Clin Nucl Med; 2013 Mar; 38(3):e112-7. PubMed ID: 23357822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-subject SPM FDG-PET patterns predict risk of dementia progression in Parkinson disease.
    Pilotto A; Premi E; Paola Caminiti S; Presotto L; Turrone R; Alberici A; Paghera B; Borroni B; Padovani A; Perani D
    Neurology; 2018 Mar; 90(12):e1029-e1037. PubMed ID: 29453242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Top-Down Systematic Approach to Interpretation of FDG-PET for Dementia.
    Sawyer DM; Kuo PH
    Clin Nucl Med; 2018 Jun; 43(6):e212-e214. PubMed ID: 29659399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autopsy as gold standard in FDG-PET studies in dementia.
    Durand-Martel P; Tremblay D; Brodeur C; Paquet N
    Can J Neurol Sci; 2010 May; 37(3):336-42. PubMed ID: 20481267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.